0001683168-22-008722.txt : 20221230
0001683168-22-008722.hdr.sgml : 20221230
20221230170255
ACCESSION NUMBER: 0001683168-22-008722
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20221230
DATE AS OF CHANGE: 20221230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Chad Norman
CENTRAL INDEX KEY: 0001949607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 221502527
MAIL ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0306
4
2022-12-29
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001949607
White Chad Norman
C/O SONOMA PHARMACEUTICALS, INC.
5445 CONESTOGA COURT, SUITE 150
BOULDER
CO
80301
0
1
0
0
Chief Financial Officer
Stock option (right to buy)
1.08
2022-12-29
4
A
0
9753
A
2032-12-29
Common Stock
9753
14753
D
The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control.
The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options.
/s/ Chad N. White
2022-12-30